CASTLE BIOSCIENCES, INC. Share-based Payment Arrangement, Accelerated Cost
CASTLE BIOSCIENCES, INC. (CSTL) reported Share-based Payment Arrangement, Accelerated Cost of $800.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. share-based payment arrangement, accelerated cost for the quarter ending 2026-06-30 was $800.00K, a 300.00% increase year-over-year.
- CASTLE BIOSCIENCES, INC. share-based payment arrangement, accelerated cost for the quarter ending 2026-03-31 was $200.00K, a 33.33% decline year-over-year.
- CASTLE BIOSCIENCES, INC. share-based payment arrangement, accelerated cost for the quarter ending 2025-12-31 was $100.00K.
- CASTLE BIOSCIENCES, INC. share-based payment arrangement, accelerated cost for the quarter ending 2025-09-30 was $200.00K, a 50.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. share-based payment arrangement, accelerated cost for fiscal 2025 was $700.00K, a 0.00% change from fiscal 2024.
- CASTLE BIOSCIENCES, INC. share-based payment arrangement, accelerated cost for fiscal 2024 was $700.00K, a 56.25% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. share-based payment arrangement, accelerated cost for fiscal 2023 was $1.60M.
- CASTLE BIOSCIENCES, INC. share-based payment arrangement, accelerated cost for fiscal 2022 was $0.00.
| Period end | Share-based Payment Arrangement, Accelerated Cost 3 month | Share-based Payment Arrangement, Accelerated Cost 6 month | Share-based Payment Arrangement, Accelerated Cost 9 month | Share-based Payment Arrangement, Accelerated Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $800.00K 10-Q · filed 2026-07-30 | $1.00M 10-Q · filed 2026-07-30 | $1.10M derived: sum of 3 quarters · filed 2026-07-30 | $1.30M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-06 | $300.00K derived: sum of 2 quarters · filed 2026-05-06 | $500.00K derived: sum of 3 quarters · filed 2026-05-06 | $700.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $300.00K derived: sum of 2 quarters · filed 2026-02-26 | $500.00K derived: sum of 3 quarters · filed 2026-07-30 | $700.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-03 | $400.00K derived: sum of 2 quarters · filed 2026-07-30 | $600.00K 10-Q · filed 2025-11-03 | $600.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $200.00K 10-Q · filed 2026-07-30 | $500.00K 10-Q · filed 2026-07-30 | $400.00K derived: sum of 3 quarters · filed 2026-07-30 | $800.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $300.00K 10-Q · filed 2026-05-06 | $200.00K derived: sum of 2 quarters · filed 2026-05-06 | $600.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $300.00K derived: sum of 2 quarters · filed 2026-02-26 | $700.00K derived: sum of 3 quarters · filed 2026-02-26 | $700.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-03 | $800.00K derived: sum of 2 quarters · filed 2025-11-03 | $800.00K 10-Q · filed 2025-11-03 | $1.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $400.00K 10-Q · filed 2025-08-04 | $600.00K 10-Q · filed 2025-08-04 | $600.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-05 | $200.00K derived: sum of 2 quarters · filed 2026-02-26 | $700.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $500.00K derived: sum of 2 quarters · filed 2026-02-26 | $900.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.60M 10-K · filed 2026-02-26 |
| 2023-09-30 | $500.00K 10-Q · filed 2024-11-04 | $900.00K derived: sum of 2 quarters · filed 2024-11-04 | $1.60M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $400.00K 10-Q · filed 2024-08-05 | $1.10M 10-Q · filed 2024-08-05 | ||
| 2023-03-31 | $700.00K 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |